Published 2009 | Version v1
Publication

An open, randomized, multicentre, phase III trial comparing the efficacy of two tamoxifen (T) schedules in preventing gynecomastia (gy) induced by bicalutamide monotherapy (BM) in prostate cancer patients (pca pts)

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023